Elicio Therapeutics, Inc.
corporate_fare Company Profile
Elicio Therapeutics, Inc. (NASDAQ:ELTX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for ELTX at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Elicio Therapeutics Reports Going Concern Doubt, Significant Dilution Amidst Clinical Progress
- Elicio Therapeutics Files $400M Universal Shelf Registration Amidst Going Concern Warning
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$39.57M
Diluted EPS
-$2.58
Op. Cash Flow
-$36.95M
Free Cash Flow
-$36.97M
Operating Income
-$37.71M
Cash & Equivalents
$18.56M
Total Debt
$9.41M
Debt / Equity
5.75×
Shares Outstanding
17.8M sh
Source: 10-K · filed 2026-04-29 · accession 0001601485-26-000035
Recent Capital Actions
-
2026-02-27 Proposed Shelf Only $400M
Detected from SEC filings (8-K, S-4, POS AM, 6-K). Last 12 months.
show_chartPrice Chart
Loading chart...